Clinical Notes: Circadian Drug Hits Trial Goal
(MedPage Today) -- Individuals whose circadian rhythms are disrupted because of total blindness achieved relief from a new drug, results of a clinical trial indicated. Also this week: Stimuvax fails to help lung cancer patients.